UBS AM
TYRA icon

UBS AM’s Tyra Biosciences TYRA Stock Holding History

UBS AM’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$565K Buy
17,688
+9,856
+126% +$326K ﹤0.01% 2513
2026
Q1 		$300K Buy
+7,832
New +$254K ﹤0.01% 2661
2025
Q2 		– Sell
-35,635
Closed -$331K – 2720
2025
Q1 		$331K Hold
35,635
– – ﹤0.01% 2549
2024
Q4 		$495K Buy
35,635
+10,426
+41% +$189K ﹤0.01% 2553
2024
Q3 		$593K Buy
+25,209
New +$529K ﹤0.01% 2602

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

UBS AM's TYRA Position: Q2 2026 in Review

UBS AM increased its Tyra Biosciences (TYRA) stake by 126% in Q2 2026, buying an estimated $326K and bringing the position to 17,688 shares worth $565K. The position accounts for ﹤0.01% of the portfolio, ranked #2513.

UBS AM first reported a position in TYRA in Q3 2024 and has held it in 5 quarters since. The position peaked at $593K in Q3 2024. 170 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • UBS AM held 17,688 shares of Tyra Biosciences worth $565K as of Q2 2026.
  • UBS AM bought 9,856 Tyra Biosciences shares in Q2 2026, an estimated $326K.
  • Tyra Biosciences made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2513 holding.
  • UBS AM first reported a position in Tyra Biosciences in Q3 2024 and has held it in 5 quarters since.
  • UBS AM's Tyra Biosciences position peaked at $593K in Q3 2024.
  • 170 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.